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Introduction
The Coronavirus Disease 2019 (COVID-19) pandemic
has had a dramatic impact on international travel. According to the US Travel Association, travel expenditure in 2020 declined by 42%, approximately $500 billion, when compared with 2019.[1] Dwindling international travel paralleled a concomitant decline in the
need for services provided by international travel clinics. Nonetheless, relationships between travel clinics
and their clientele blossomed during this period. Having expertise in specialized preventive care and public
health, travel clinics are equipped with the knowledge
of infectious diseases to establish new avenues for patient and community support during the pandemic and
beyond. In this perspective, approaches taken at the Division of Infectious Diseases International Travel Clinic
at the University of Louisville (UL Travel Clinic) will
be used as a model, demonstrating avenues in which
travel clinic services might pivot to meet community
needs during the ongoing COVID-19 pandemic and beyond.

Pre-Pandemic Travel Clinic Services
Travel clinics in the United States and worldwide have
maintained their as primary focus the provision of preventive medical care for anticipating travelers. This
preventive care utilizes a risk-based approach that addresses the epidemiology of destinations in a travel
itinerary, current health and vaccination history of the
traveler, specifics of the travel experience, and the desire of the individual to minimize risks associated with
current and future travel experiences. The resultant
all-encompassing care plan includes vaccines, medications, and alternative preventive adjuncts and is influenced by guidelines such as the Centers for Disease
Control and Prevention (CDC) Yellow Book and World
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Health Organization (WHO) recommendations, entailing risk-based guidance concerning COVID-19.[2, 3]
For more than 20 years, the UL Travel Clinic has
been operating full-service, providing care for international travelers before, during, and after travel. Clinic
personnel—board-certified in infectious diseases, tropical medicine, and infection control and International
Society of Travel Medicine–certified in travel health
(CTH® )—work closely with the Division of Infectious
Diseases’ Clinical Laboratory Improvement Amendments (CLIA)–certified clinical and research laboratory
to provide their full spectrum of services. In addition
to the on-site availability of all U.S. Food & Drug Administration (FDA)–approved vaccines, vaccine clinical trials are also performed by research investigators
within the Division. The storage of these vaccines is
under meticulous management by the Travel Clinic
personnel due to fine temperature storage and documentation requirements. Physicians, advanced practice and registered nurses, public health professionals,
medical technologists, and laboratory scientists working in the UL Travel Clinic have broad competencybased skillsets, including client care, vaccine handling
and management, vaccine administration, specimen
collection and handling, infection control, public health
surveillance and disease reporting, compliance with
Vaccine for Children (VFC) program requirements, use
of electronic medical records and state immunization
information systems, and database development. Supplies maintained in the clinic include those needed for
vaccination, as well as personal protective equipment
(PPE) for specimen collection. PPE includes gowns,
gloves, masks, face shields, and N95 respirators. The
combination of an extensive resource pool and welldesigned clinic operations has enabled the provision
of concierge-level care for travelers, forming the basis
of new services provided during the COVID-19 pandemic.
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Travel Clinic Services During the COVID-19
Pandemic
By March 2020, international leisure travel had come to
a virtual halt. As experts well-acquainted with specimen collection and PPE use and management, UL
Travel Clinic personnel switched gears to provide assistance to the local health care scene. They began
working with local hospitals and health care facilities to
expand testing capacity for in-patients and long-term
care residents during the initial wave of the pandemic.
In addition, the laboratory personnel began working
with Luminex to validate a laboratory-developed polymerase chain reaction (PCR) test for the SARS-CoV-2
virus. This test was validated by FDA emergency use
authorization (EUA) in April 2020 [4-6], subsequently
enabling Travel Clinic personnel to begin providing
COVID-19 PCR tests for the community, as well as businesses engaged in international travel. Bioinformaticians and database managers in the Division of Infectious Diseases were consulted to assist in development
of a REDCap® database to facilitate electronic registration for COVID-19 testing and support public health
surveillance and report.[7]
Testing is performed via a curbside service (Figure 1).
Individuals seeking COVID-19 testing are emailed a
link to the online registration database. Upon arrival
to the clinic parking lot, individuals remain in their
cars while clinic personnel perform the nasopharyngeal specimen collection. Thereafter, the PCR laboratory tests are conducted by laboratory personnel, with
results made available within 24 hours’ turnaround
time. With the recommencement of international travel
in the Fall of 2020, the database was used to provide
documentation of test results required by airlines and
various international immigration regulations. Face-toface engagement for travel-related counseling occurred
virtually via a HIPAA-compliant Zoom platform, while
post-consult vaccinations would be carried out curbside in the parking lot.
In December 2020, when the COVID-19 vaccines were
released under EUA, the Travel Clinic was able to increase the capacity of local vaccination efforts. Mass
vaccination training was provided as part of the
Louisville Vaccination efforts (LouVax), and Travel
Clinic personnel assisted with the 17-week operation of
LouVax Broadbent, the drive-through community vaccination site (Figure 2). At that site, over 105,000 doses
of vaccine were administered by a workforce of more
than 2,000 health care workers; Travel Clinic personnel
developed and coordinated the vaccine handling and
vaccine administration training program for that workforce.[8] Due to clinic experience and demonstration of
vaccine handling competence evidenced by participation in the state’s Vaccines for Children (VFC) program,
the Travel Clinic was able to obtain COVID-19 vaccines
on site and provide them to members of the community
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on a walk-in/drive-up basis.
Community engagement throughout the first year of
the COVID-19 pandemic also provided opportunities
for research within the Division of Infectious Diseases.
With the involvement of researchers, protocols were
developed to engage patients seeking COVID-19 testing and/or vaccination at the Travel Clinic in research
participation. Personnel of the Travel Clinic assisted
with the exchange of information regarding Division
research activities and the enrollment of research participants. The drive-up mode of research testing was
conducted by the Travel Clinic when in-facility testing was not required by the research protocol. Environmental infection control practices were in place to
safely facilitate interactions that required in-facility research testing.

Re-imagining Travel Clinic Services Beyond the COVID-19 Pandemic
The COVID-19 pandemic has both required and enabled a transformation of services provided by international travel clinics. The use of technologies such as
those enabling virtual connections for pre-travel counseling (e.g., Zoom), increasing use of laboratory testing (e.g., PCR for COVID-19) as part of travel services,
and integration of drive-through or curbside vaccination are just a few examples of services that international travel clinics may encompass in 2022 and beyond.
Based on the experiences gleaned from the 2020–2021
phase of the COVID-19 pandemic and its impact on the
UL Travel Clinic, approaches to reimagine the services
of international travel clinics are outlined below:
• Develop processes to engage with international
travelers using a virtual component (e.g., Zoom).
• Ensure that the virtual engagement process protects the privacy and health information of the
client.
• Train clinic personnel in modes of disease transmission and provide them with appropriate PPE,
including fit-tested respirators.
• Maintain stock of PPEs, injection supplies, and
specimen collection equipment, recognizing the
typical long shelf life of many of the aforementioned items upon storage under proper environmental conditions.
• Train clinic personnel to engage with clients, administer vaccines, and perform specimen collection via drive-through or curbside approaches.
• Establish and maintain a working relationship
with a CLIA-certified laboratory.
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Figure 1. Curbside testing service process for SARS-CoV-2 infection.
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Figure 2. LouVax drive-through vaccination for SARS-CoV-2 at Broadbent Arena, Louisville, KY.
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• Evaluate current clinic location, space, and capabilities to enable expansion or changes in client
engagement.
• Establish and maintain working relationships
with local public health departments or districts.
• Train clinic personnel regarding local reportable
disease and surveillance regulations, including
clinic responsibilities for reporting of results.
• Engage clients, possibly through an informal advisory board process, to better understand needs
and expectations.
• Develop and implement competency-based training to ensure clinic personnel are competent to
perform every aspect of their work.
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• Engage with local university/universities and establish dialogue regarding travel clinic capabilities as a means of furthering local research capabilities and capacities.

These points are by no means all-inclusive but are
meant to be a starting point to facilitate discussions
across the public health and travel clinic industries.
Services provided by international travel clinics are vital for the health and safety of the population. Enabling
continuation and expansion of those services to address
the current pandemic, as well as emerging pathogens
or new pathogens, is crucial for the health and welfare
of populations worldwide.
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